Dianthus Therapeutics, Inc.: cashflow_financing

Value{"amount": 749790000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2026-01-01 – 2026-06-30
Statuscurrent
EntityDianthus Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001690585-26-000034 · Open the official SEC filing →
Retrieved: 2026-08-19T17:19:32.661739+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001690585/cashflow-financing/2026-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/4e70cf5f-93fd-407d-8f4c-a2ba6181e72d

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies